Tradestie Institutional Equity Comparison Engine

ERAS vs DSGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ERAS Overall Edge

ERAS Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Erasca, Inc. Common Stock (ERAS) driven by superior Momentum & Technical, Options & Structure while DSGN counters with relative strength in Growth & Margin. Fundamentally, ERAS trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus DSGN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ERAS sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro) against DSGN sits in BREAKDOWN (13th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ERAS N/M vs DSGN N/M Fwd P/E
Growth & Margin Winner DSGN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ERAS
1Y +488.4% vs +40.8% ยท 52W Pos 57% vs 30%
Options & Structure Winner ERAS
BREAKDOWN (13th %ile IV) vs BREAKDOWN (13th %ile IV)
ERAS NASDAQ
Erasca, Inc. Common Stock
Pharmaceutical Preparations
$14.95
-4.57% 1D
Market Cap $5.5B
1M Return +11.61%
1Y Return +488.39%
Forward P/E N/M
Unified AI Score
37.5 / 100 SELL
Tech 20.0 Fund 47.0 Flow 70.0 Mom 64.0
DSGN NASDAQ
Design Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.94
-5.06% 1D
Market Cap $677.5M
1M Return -3.59%
1Y Return +40.79%
Forward P/E N/M
Unified AI Score
49.8 / 100 HOLD
Tech 55.0 Fund 57.0 Flow 63.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ERAS +488.39% DSGN +40.79% Spread: +447.6 pp (ERAS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ERAS TTM Op. Margin: 0.0% DSGN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ERAS vs DSGN. Trailing 12-month operating profitability (ERAS 0.0% vs DSGN 0.0%) and valuation multiples (ERAS N/M vs DSGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ERAS (2) vs DSGN (3)
Institutional Metric ERAS DSGN Criterion Row Winner
Market Capitalization Scale $5.5B $677.5M Larger Scale ERAS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -48.7% -36.9% Higher ROE DSGN
52-Week Range Position Momentum 57% ($2โ€“$24) 30% ($7โ€“$17) Stronger Trend ERAS
Beta / 30D Volatility Risk Regime 2.31ฮฒ ยท 81% Vol 1.32ฮฒ ยท 61% Vol Lower Realized Risk DSGN
Unified Institutional Score Composite Signal 37.5 / 100 (SELL) 49.8 / 100 (HOLD) Higher Composite DSGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ERAS vs DSGN Buy Guide
ERAS BREAKDOWN
87d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live ERAS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DSGN BREAKDOWN
139d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live DSGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ERAS nor DSGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.